Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 AUD | -.--% | -.--% | -.--% |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drug Development
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -92.24% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -92.24% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 23-01-04 | |
Director of Finance/CFO | 62 | 23-06-30 | |
Chief Tech/Sci/R&D Officer | - | 23-06-30 | |
Julie Kerner
COO | Chief Operating Officer | - | 23-06-30 |
Liz Doolin
CTO | Chief Tech/Sci/R&D Officer | 59 | 07-12-31 |
Adrian Hinton
AUD | Comptroller/Controller/Auditor | 72 | 19-04-30 |
Rajeev Chandra
SEC | Corporate Secretary | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Wilson
BRD | Director/Board Member | 61 | 16-06-15 |
Alan Fisher
CHM | Chairman | 71 | 16-08-31 |
Jane Ryan
BRD | Director/Board Member | 65 | 20-09-30 |
Aaron Weaver
BRD | Director/Board Member | 43 | 20-07-05 |
Chief Executive Officer | 52 | 23-01-04 | |
Peter Davies
BRD | Director/Board Member | 43 | 21-06-30 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- BNOX Stock
- BNO Stock
- Company Bionomics